Literature DB >> 3492804

Methyldopa-induced connective tissue disorder.

M J Power, J G McConnell, I C Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3492804      PMCID： PMC2448359     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  7 in total

1.  Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects.

Authors:  J D MORROW; H A SCHROEDER; H M PERRY
Journal:  Circulation       Date:  1953-12       Impact factor: 29.690

2.  Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa.

Authors:  A Breckenridge; C T Dollery; S M Worlledge; E J Holborow; G D Johnson
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

Review 3.  Drug-induced lupus: clinical spectrum and pathogenesis.

Authors:  J J Cush; E A Goldings
Journal:  Am J Med Sci       Date:  1985-07       Impact factor: 2.378

4.  Lupus-like syndrome induced by methyldopa.

Authors:  A Dupont; R Six
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

Review 5.  Drug-induced lupus: clinical and serological studies.

Authors:  C E Harmon; J P Portanova
Journal:  Clin Rheum Dis       Date:  1982-04

6.  Systemic lupus-like syndrome induced by methyldopa therapy.

Authors:  T M Harrington; D E Davis
Journal:  Chest       Date:  1981-06       Impact factor: 9.410

7.  Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia.

Authors:  H H Kirtland; D N Mohler; D A Horwitz
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.